Akynzeo
Total Payments
$18,001
Transactions
4
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $16,501 | 3 | 1 |
| 2017 | $1,500 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $8,296 | 1 | 46.1% |
| Honoraria | $7,683 | 1 | 42.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,500 | 1 | 8.3% |
| Food and Beverage | $521.97 | 1 | 2.9% |
Top Doctors Receiving Payments for Akynzeo
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Hematology & Oncology | New York, NY | $18,001 | 4 |
Ad
Manufacturing Companies
- Vifor (International) Ltd. $18,001
Product Information
- Type Drug
- Total Payments $18,001
- Total Doctors 1
- Transactions 4
About Akynzeo
Akynzeo is a drug associated with $18,001 in payments to 1 healthcare providers, recorded across 4 transactions in the CMS Open Payments database. The primary manufacturer is Vifor (International) Ltd..
Payment data is available from 2017 to 2019. In 2019, $16,501 was paid across 3 transactions to 1 doctors.
The most common payment nature for Akynzeo is "Travel and Lodging" ($8,296, 46.1% of total).